 | This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Guacetisal" – news ·newspapers ·books ·scholar ·JSTOR(November 2023) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
| Other names | Aspirin guaiacol ester;O-Methoxyphenyl salicylate acetate |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.054.221 |
| Chemical and physical data | |
| Formula | C16H14O5 |
| Molar mass | 286.283 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
| |
Guacetisal is a drug that has been used to treatinflammatory respiratory diseases.[1] Chemically, it is anester resulting from the combination ofaspirin andguaiacol.[citation needed]
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;†withdrawn drugs;‡veterinary use. | |
 | Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byadding missing information. |
